Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
26.29
-2.36 (-8.24%)
Feb 21, 2025, 4:00 PM EST - Market closed
Korro Bio Employees
As of December 31, 2023, Korro Bio had 102 total employees, including 101 full-time and 1 part-time employees.
Employees
102
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$860,863
Market Cap
246.29M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
KRRO News
- 3 months ago - Korro to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency - GlobeNewsWire
- 3 months ago - Korro to Present at the Jefferies London Healthcare Conference - GlobeNewsWire
- 3 months ago - Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board - GlobeNewsWire
- 5 months ago - Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society - GlobeNewsWire
- 6 months ago - Korro to Participate in Upcoming September Investor and Scientific Conferences - GlobeNewsWire
- 6 months ago - Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 9 months ago - Korro to Participate in Upcoming June Investor and Scientific Conferences - GlobeNewsWire